Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.
2.

Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.

Koff RS.

J Clin Gastroenterol. 2001 Jul;33(1):20-6. Review.

PMID:
11418785
3.

A virological perspective on the need for vaccination.

Locarnini S.

J Viral Hepat. 2000 May;7 Suppl 1:5-6. Review.

PMID:
10866836
4.

Experience with hepatitis A and B vaccines.

Davis JP.

Am J Med. 2005 Oct;118 Suppl 10A:7S-15S. Review.

PMID:
16271535
5.

Screening for hepatitis A and B antibodies in patients with chronic liver disease.

Lau DT, Hewlett AT.

Am J Med. 2005 Oct;118 Suppl 10A:28S-33S. Review.

PMID:
16271538
7.

Education provides significant benefits to patients with hepatitis B virus or hepatitis C virus infection: a systematic review.

Shah HA, Abu-Amara M.

Clin Gastroenterol Hepatol. 2013 Aug;11(8):922-33. doi: 10.1016/j.cgh.2013.04.024. Epub 2013 Apr 29. Review.

PMID:
23639601
8.

Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases.

Keeffe EB.

Trans Am Clin Climatol Assoc. 2006;117:227-37; discussion 237-8. Review.

9.

Fulminant hepatitis A in patients with chronic liver disease.

Lefilliatre P, Villeneuve JP.

Can J Public Health. 2000 May-Jun;91(3):168-70. Review.

PMID:
10927841
10.

Factors associated with hepatitis B vaccination among men who have sex with men: a systematic review of published research.

Vet R, de Wit JB, Das E.

Int J STD AIDS. 2017 May;28(6):534-542. doi: 10.1177/0956462415613726. Epub 2015 Oct 25. Review.

PMID:
26503555
11.

Hepatitis A and hepatitis B vaccination of patients with chronic liver disease.

Bell BP.

Acta Gastroenterol Belg. 2000 Oct-Dec;63(4):359-63. Review. No abstract available.

PMID:
11233518
12.

Testing and reporting practices for improved management of hepatitis C.

Pesano RL.

Antivir Ther. 2012;17(7 Pt B):1403-7. doi: 10.3851/IMP2467. Epub 2012 Dec 7. Review.

PMID:
23322643
13.

Extension for Community Health Outcomes-hepatitis C: Small steps carve big footprints in the allocation of scarce resources for hepatitis C virus treatment to remote developing areas.

Tahan V, Almashhrawi A, Kahveci AM, Mutrux R, Ibdah JA.

World J Hepatol. 2016 Apr 18;8(11):509-12. doi: 10.4254/wjh.v8.i11.509. Review.

Supplemental Content

Support Center